Scalper1 News
Illumina (ILMN) surpassed second quarter earnings estimates late Tuesday but missed on revenue for the first time in six years. Analysts expected a beat-and-raise from the maker of gene sequencing systems, so its shares suffered in the stock market today. Illumina stock gapped down 8.4% in huge volume on Wednesday, breaching its 50-day moving average intraday. But the stock was able to recover some of those losses and is now back above that key Scalper1 News
Scalper1 News